DGX logo

DGX

Quest Diagnostics Incorporated

$185.00
-$2.03(-1.09%)
80
Overall
100
Value
90
Tech
50
Quality
Market Cap
$20.23B
Volume
1.00M
52W Range
$157.20 - $197.55
Target Price
$199.47

Company Overview

Mkt Cap$20.23BPrice$185.00
Volume1.00MChange-1.09%
P/E Ratio23.2Open$186.01
Revenue$9.9BPrev Close$187.03
Net Income$871.0M52W Range$157.20 - $197.55
Div Yield3.20%Target$199.47
Overall80Value100
Quality50Technical90

No chart data available

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Synergy CHC (SNYR) and Humana (HUM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quest Diagnostics (DGX – Research Report), Synergy CHC (SNYR – Re...

Catie Powersa day ago

Digi Power X Advances AI Infrastructure Strategy with PTC 2026 Presence and ARMS 200 Rollout

TipRanks Canadian Auto-Generated Newsdesk14 days ago

Bernstein Sticks to Their Buy Rating for Dollar General (DG)

TipRanks Auto-Generated Intelligence Newsdesk19 days ago

Evercore ISI Remains a Hold on Quest Diagnostics (DGX)

TipRanks Auto-Generated Intelligence Newsdesk21 days ago

Quest Diagnostics Highlights Growth Strategy at Healthcare Conference

TipRanks Auto-Generated Newsdesk22 days ago
ABCD
1SymbolPriceChangeVol
2DGX$185.00-1.1%1.00M
3
4
5
6

Get Quest Diagnostics Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.